Table of Contents
2019-2024 Global Precision Cancer Diagnostic Tests Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Precision Cancer Diagnostic Tests Market Size 2014-2024
2.1.2 Precision Cancer Diagnostic Tests Market Size CAGR by Region
2.2 Precision Cancer Diagnostic Tests Segment by Type
2.2.1 Imaging
2.2.2 Molecular
2.2.3 Histology/Cytology
2.2.4 Tumor Marker Immunoassays
2.2.5 POC Colon Cancer Tests
2.3 Precision Cancer Diagnostic Tests Market Size by Type
2.3.1 Global Precision Cancer Diagnostic Tests Market Size Market Share by Type (2014-2019)
2.3.2 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type (2014-2019)
2.4 Precision Cancer Diagnostic Tests Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Precision Cancer Diagnostic Tests Market Size by Application
2.5.1 Global Precision Cancer Diagnostic Tests Market Size Market Share by Application (2014-2019)
2.5.2 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Application (2014-2019)
3 Global Precision Cancer Diagnostic Tests by Players
3.1 Global Precision Cancer Diagnostic Tests Market Size Market Share by Players
3.1.1 Global Precision Cancer Diagnostic Tests Market Size by Players (2017-2019)
3.1.2 Global Precision Cancer Diagnostic Tests Market Size Market Share by Players (2017-2019)
3.2 Global Precision Cancer Diagnostic Tests Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Precision Cancer Diagnostic Tests by Regions
4.1 Precision Cancer Diagnostic Tests Market Size by Regions
4.2 Americas Precision Cancer Diagnostic Tests Market Size Growth
4.3 APAC Precision Cancer Diagnostic Tests Market Size Growth
4.4 Europe Precision Cancer Diagnostic Tests Market Size Growth
4.5 Middle East & Africa Precision Cancer Diagnostic Tests Market Size Growth
5 Americas
5.1 Americas Precision Cancer Diagnostic Tests Market Size by Countries
5.2 Americas Precision Cancer Diagnostic Tests Market Size by Type
5.3 Americas Precision Cancer Diagnostic Tests Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Precision Cancer Diagnostic Tests Market Size by Countries
6.2 APAC Precision Cancer Diagnostic Tests Market Size by Type
6.3 APAC Precision Cancer Diagnostic Tests Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Precision Cancer Diagnostic Tests by Countries
7.2 Europe Precision Cancer Diagnostic Tests Market Size by Type
7.3 Europe Precision Cancer Diagnostic Tests Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Precision Cancer Diagnostic Tests by Countries
8.2 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Type
8.3 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Precision Cancer Diagnostic Tests Market Forecast
10.1 Global Precision Cancer Diagnostic Tests Market Size Forecast (2019-2024)
10.2 Global Precision Cancer Diagnostic Tests Forecast by Regions
10.2.1 Global Precision Cancer Diagnostic Tests Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Precision Cancer Diagnostic Tests Forecast by Type
10.8 Global Precision Cancer Diagnostic Tests Forecast by Application
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Company Details
11.1.2 Precision Cancer Diagnostic Tests Product Offered
11.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Abbott Laboratories News
11.2 Agilent Technologies, Inc.
11.2.1 Company Details
11.2.2 Precision Cancer Diagnostic Tests Product Offered
11.2.3 Agilent Technologies, Inc. Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Agilent Technologies, Inc. News
11.3 Becton Dickinson and Company
11.3.1 Company Details
11.3.2 Precision Cancer Diagnostic Tests Product Offered
11.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Becton Dickinson and Company News
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Company Details
11.4.2 Precision Cancer Diagnostic Tests Product Offered
11.4.3 Bio-Rad Laboratories, Inc. Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Bio-Rad Laboratories, Inc. News
11.5 Biocartis N.V.
11.5.1 Company Details
11.5.2 Precision Cancer Diagnostic Tests Product Offered
11.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Biocartis N.V. News
11.6 Biocept, Inc.
11.6.1 Company Details
11.6.2 Precision Cancer Diagnostic Tests Product Offered
11.6.3 Biocept, Inc. Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Biocept, Inc. News
11.7 bioMerieux SA
11.7.1 Company Details
11.7.2 Precision Cancer Diagnostic Tests Product Offered
11.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 bioMerieux SA News
11.8 Canon Medical Systems Corporation
11.8.1 Company Details
11.8.2 Precision Cancer Diagnostic Tests Product Offered
11.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Canon Medical Systems Corporation News
11.9 Cynvenio Biosystems, Inc.
11.9.1 Company Details
11.9.2 Precision Cancer Diagnostic Tests Product Offered
11.9.3 Cynvenio Biosystems, Inc. Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Cynvenio Biosystems, Inc. News
11.10 Danaher Corporation
11.10.1 Company Details
11.10.2 Precision Cancer Diagnostic Tests Product Offered
11.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Danaher Corporation News
11.11 Epigenomics AG
11.12 Exosome Diagnostics, Inc.
11.13 Foundation Medicine, Inc.
11.14 General Electric Company
11.15 Genomic Health, Inc.
11.16 Hologic, Inc.
11.17 Illumina, Inc.
11.18 Menarini Silicon Biosystems SpA
11.19 Myriad Genetics, Inc.
11.20 NanoString Technologies, Inc.
11.21 Ortho Clinical Diagnostics
11.22 QIAGEN N.V.
11.23 Randox Laboratories Ltd.
11.24 Roche Holding AG
11.25 Royal Philips N.V.
11.26 Siemens AG
11.27 Thermo Fisher Scientific
11.28 Vela Diagnostics
12 Research Findings and Conclusion
